MedPath

A study to assess whether factor VIII given once a week will prevent major bleeds in severe hemophilia A

Phase 4
Conditions
Health Condition 1: null- Children with Severe Hemophilia A
Registration Number
CTRI/2014/12/005277
Lead Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
21
Inclusion Criteria

children 1-12 years of age with severe hemophilia A and no detectable inhibitors are recruited to the study

Exclusion Criteria

children, whose parents do not give a written informed consent and children with any other bleeding diathesis are excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath